Evidence map›Paper›PMID 34120649›Full record

ArticleTrials2021

Impact of a mobile phone-based interactive voice response software on tuberculosis treatment outcomes in Uganda (CFL-TB): a protocol for a randomized controlled trial.

Dathan Mirembe Byonanebye, Hope Mackline, Christine Sekaggya-Wiltshire, Agnes N Kiragga, Mohammed Lamorde, Elizabeth Oseku, Rachel King, Rosalind Parkes-Ratanshi

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04709159 (Impact of Mobile Health Interactive Software on Tuberculosis Treatment Outcomes), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04709159 naunknown statusnot on this map

Impact of Mobile Health Interactive Software on Tuberculosis Treatment Outcomes: The Call for Life (CFLU-TB) Project

TypeinterventionalSponsorMakerere UniversityRan2020 to 2022Enrolled274ConditionsTuberculosisArmsCall for Life Uganda
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Scoping review of health information technology usability methods leveraged in Africa.Journal of the American Medical Informatics Association : JAMIA · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dathan Mirembe ByonanebyeMakerere University School of Public Health, P.O. Box 7072, Kampala, Uganda. dbyonanebye@musph.ac.ug.ORCID http://orcid.org/0000-0001-9862-4724
Hope MacklineInfectious Diseases Institute, Makerere University, P.O. Box 22418, Kampala, Uganda.
Christine Sekaggya-WiltshireInfectious Diseases Institute, Makerere University, P.O. Box 22418, Kampala, Uganda.
Agnes N KiraggaInfectious Diseases Institute, Makerere University, P.O. Box 22418, Kampala, Uganda.
Mohammed LamordeInfectious Diseases Institute, Makerere University, P.O. Box 22418, Kampala, Uganda.
Elizabeth OsekuInfectious Diseases Institute, Makerere University, P.O. Box 22418, Kampala, Uganda.
Rachel KingInfectious Diseases Institute, Makerere University, P.O. Box 22418, Kampala, Uganda.
Rosalind Parkes-RatanshiInfectious Diseases Institute, Makerere University, P.O. Box 22418, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThroughout the last decade, tuberculosis (TB) treatment success has not surpassed 90%, the global target. The impact of mobile health interventions (MHIs) on TB treatment outcomes is unknown, especially in low- and middle-income countries (LMICs). MHIs, including interactive voice response technology (IVRT), may enhance adherence and retention in the care of patients with tuberculosis and improve TB treatment outcomes. This study seeks to determine the impact of IVRT-based MHI on TB treatment success (treatment completion and cure rates) in patients with TB receiving care at five public health facilities in Uganda.

methodsWe used a theory-based and human-centered design (HCD) to adapt an already piloted software to design "Call for life-TB" (CFL-TB), an MHI that utilizes IVRT to deliver adherence and appointment reminders and allows remote symptom reporting. This open-label, multicenter, randomized controlled trial (RCT), with nested qualitative and economic evaluation studies, will determine the impact of CFL-TB on TB treatment success in patients with drug-susceptible TB in Uganda. Participants (n = 274) at the five study sites will be randomized (1:1 ratio) to either control (standard of care) or intervention (adherence and appointment reminders, and health tips) arms. Multivariable regression models will be used to compare treatment success, adherence to treatment and clinic appointments, and treatment completion at 6 months post-enrolment. Additionally, we will determine the cost-effectiveness, acceptability, and perceptions of stakeholders. The study received national ethical approval and was conducted in accordance with the international ethical guidelines. DISCUSSION: This randomized controlled trial aims to evaluate interactive voice response technology in the context of resource-limited settings with a high burden of TB and high illiteracy rates. The software to be evaluated was developed using HCD and the intervention was based on the IMB model. The software is tailored to the local context and is interoperable with the MHI ecosystem. The HCD approach ensures higher usability of the MHI by integrating human factors in the prototype development. This research will contribute towards the understanding of the implementation and impact of the MHI on TB treatment outcomes and the health system, especially in LMICs.

trial registrationClinicalTrials.gov NCT04709159 . Registered on January 14, 2021.

Indexed as

Cell PhoneTuberculosisHumansMulticenter Studies as TopicRandomized Controlled Trials as TopicSoftwareTreatment OutcomeUgandaAfricaInteractive voice responseLow - and middle-income countriesmHealthResource-limited settingstuberculosis

Identifiers

PMID34120649
PMCPMC8201814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.